Triethanalamine trinitrate bisphosphate, also known as metamine, is an older medication that was historically used to treat angina pectoris, a chest pain condition caused by reduced blood flow to the heart.
Here's what we know about triethanolamine trinitrate bisphosphate:
- Limited Use: Information on this medication is limited, with research mainly concentrated in the 1950s. It's no longer a common treatment for angina pectoris.
- Function: Triethanalamine trinitrate bisphosphate belongs to a class of drugs called nitrates. Nitrates work by relaxing blood vessels, which can improve blood flow to the heart and alleviate chest pain associated with angina.
- Delivery Method: Research suggests it may have been available in a sustained-release form, meaning it would release the medication slowly over time.
Why it's not commonly used anymore:
- Limited information: There's a lack of recent studies on the effectiveness and safety of triethanolamine trinitrate bisphosphate compared to newer medications for angina.
- Availability: It's likely no longer commercially available due to the existence of more modern and well-studied medications for angina.
Current Treatment Options:
Several medications are more commonly used to treat angina pectoris today. These include:
- Beta-blockers: Reduce heart rate and blood pressure, lowering the heart's workload.
- Calcium channel blockers: Relax blood vessels and improve blood flow to the heart.
- Nitrates: Similar to triethanolamine trinitrate bisphosphate, but there are newer nitrate medications with potentially better side effect profiles.